Several gene therapies are or will soon be in late-stage human trials. One of them could be the first to get FDA approval for sale in the U.S.
An upcoming film, The Perfect 46, is about a fictional genomics company with a not-so-fictional idea.
Despite promising results in controlling neuronal activity, leaders in brain research still wrestle over turning their work into treatments.
A new company launched by Google will seek to extend human life spans.
Notre Dame researchers will test a concussion-detection app on nearly a thousand high school and youth football players.
Researchers are using smart helmets and imaging to study brain injury risk in young football players over a season.
New research indicates that chemical fingerprints can make positive matches between batches of sarin.
By studying the interactions between our bodies and our microbes, a startup hopes to find new ways of treating disease.
Nektar Therapeutics is developing a painkiller that may enter the brain too slowly to be abused.